Moxonidine suitable for hypertensive menopausal women with metabolic syndrome.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use*; D020738:Leptin / Q000378:metabolism; D008593:Menopause / Q000187:drug effects*; D024821:Metabolic Syndrome / Q000150:complications* / Q000188:drug therapy; D012084:Renin-Angiotensin System / Q000187:drug effects
D000959:Antihypertensive Agents; D001786:Blood Glucose; D002395:Catecholamines; D007093:Imidazoles; D020738:Leptin; C043482:moxonidine